Bayer Pharma AG v. Watson Laboratories, Inc.
Bayer Pharma AG v. Watson Laboratories, Inc., 16-2169
In a patent infringement action, the district court’s judgment for plaintiff Bayer is reversed where it clearly erred in determining that a skilled artisan would not have been motivated to create an oral disintegrating tablet version of an erectile dysfunction drug using specified sugar alcohols with the tablet formulated for immediate-release.
- Published 2017/11/01
- United States Federal Circuit